MI-LINEAGE-LOGISTICS
10.11.2021 16:44:04 CET | Business Wire | Press release
Lineage Logistics, LLC, the world’s largest and most innovative temperature-controlled industrial REIT and logistics solutions provider, today announced the installation of groundbreaking clean energy advancements at its facility in Colton, CA to establish the first facility in the Lineage network to generate 100% of its energy consumption on-site.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211110005987/en/
This announcement comes in tandem with Lineage’s commitment to becoming net-zero carbon by 2040 as a signatory of The Climate Pledge, representing the Company’s industry-leading charge for a more sustainable cold chain.
Aligned with President Biden’s announcement on October 13, 2021 to invest in a secure and sustainable supply chain in the United States, Lineage has installed a 3.3MW solar array and 460kW of linear generators at its Colton Agua Mansa facility in California’s Inland Empire that, combined, will produce 100% of the facility’s energy consumption on a net basis. These advancements are indicative of Lineage’s continued prioritization of energy reduction, which started with the introduction of the Company’s responsible energy reduction roadmap in 2015.
“Lineage always strives to be responsible leaders in the communities where we live and work, and our commitment to advancing the future of renewable energy at our locations is no exception,” said Chris Thurston, head of renewable energy projects for Lineage. “Lineage is already a model for the industry with our innovative development and deployment of industry-leading technologies. Responsibly creating our own energy is an important sustainability milestone, and I am excited to see how this achievement further inspires our commitment to carbon neutrality by 2040.”
Lineage partnered with PowerFlex, a national provider of renewable energy infrastructure, to install the rooftop solar array in Colton – the second largest solar array in the Company’s leading global network of temperature-controlled warehouses. The facility has 8,426 individual solar panels that will generate an estimated 5.4 million kilowatt-hours (kWh) of clean energy annually. The Colton array is one of several onsite solar installations that PowerFlex is supporting across Lineage’s distribution centers in the United States.
“As Lineage’s long-term partner in renewable energy, we are incredibly proud to share and help execute their bold vision for impactful solar solutions across their extensive network,” said PowerFlex Director Danny Ptak. “The onsite solar project in Colton demonstrates Lineage’s ongoing commitment to deploying innovative solutions to ensure that its operations are as sustainable as humanly possible.”
The onsite linear generators, a new technology launched in March by Mainspring Energy, create electricity using a low-temperature reaction of fuel and air. Distinct from an engine or fuel cell, a linear generator directly converts motion into electricity using chemical or thermal energy. The units ramp up and down usage to enable maximum use of the building’s solar array, ensuring reliability and optimal use of renewable power at all times. This increases the site’s resiliency by reducing grid dependency and lowers operating costs. Lineage’s Colton location is the first facility in the world with two linear generators, and the first of its kind to integrate a linear generator with solar panels. The two generators were installed in October.
“Commercial and industrial buildings account for more than a third of electricity usage in the United States and play an essential role in the energy transition,” said Mainspring CEO Shannon Miller. “Mainspring designed the linear generator to accelerate this transition by delivering resilient, sustainable, and affordable generation that is also ideal for pairing with solar and other renewables. We are proud to partner with Lineage, an industry leader and pioneer in deploying innovative energy technologies.”
In December 2020, Lineage’s increased its commitment to energy reduction by implementing new and innovative technologies. In 2021, Lineage was recognized by the United States Department of Energy for Outstanding Accomplishments in Energy Efficiency for the third year in a row and the Department of Energy’s Better Plants Challenge with a commitment to reduce energy intensity by 25% by 2024.
About Lineage Logistics
Lineage Logistics is the world’s largest temperature-controlled industrial REIT and logistics solutions provider. It has a global network of over 400 strategically located facilities totaling over 2 billion cubic feet of capacity which spans 19 countries across North America, Europe and Asia-Pacific. Lineage’s industry-leading expertise in end-to-end logistical solutions, its unrivaled real estate network, and development and deployment of innovative technology help increase distribution efficiency, advance sustainability, minimize supply chain waste, and most importantly, as a Visionary Partner of Feeding America, help feed the world. In recognition of the company’s leading innovations and sustainability initiatives, Lineage was listed as No. 17 in the 2021 CNBC Disruptor 50 list, the No 1. Data Science company, and 23rd overall, on Fast Company’s 2019 list of The World’s Most Innovative Companies, in addition to being included on Fortune’s Change The World list in 2020. (www.lineagelogistics.com )
About PowerFlex
PowerFlex delivers commercial and industrial customers a full range of turnkey clean energy solutions: solar, storage, smart EV charging, microgrids, and energy management systems. The Company was founded in 2017 by a Caltech research group who developed a patented Adaptive Load Management (ALM) technology to optimize power consumption across a large network of charging stations. PowerFlex Systems was acquired by EDF Renewables North America in 2019, and consolidated with EnterSolar, a leading commercial solar developer, in 2021 to expand its onsite solar offerings. For more information, visit www.powerflex.com .
About Mainspring Energy
Driven by its vision of the affordable, reliable, net-zero carbon grid of the future, Mainspring is delivering a new category of power generation — the linear generator — that delivers onsite, dispatchable, fuel-flexible power at low cost. Based in Menlo Park, Calif., Mainspring is backed by top-tier venture, strategic, and financial investors. www.mainspringenergy.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20211110005987/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Biocytogen Grants Taisho Pharmaceutical a License to its RenNano® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 13:00:00 CEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro
Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform30.3.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional seasonal flu vaccines, which must be manufactured annually based on recommended candidate vaccine viruses, Centivax’s platform focuses both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate and are shared across strains and distant subtypes. This approach aims to generate broad, consistent, and durable immunity against both seasonal and pandemic influenza. Meiji’s strategic investment aims to accelerate the advancement of Centi-Flu 01 and further a
Samsung Biologics Strike: Labor Union Warns of CDMO Supply Chain Risks Following Overwhelming Vote30.3.2026 11:52:00 CEST | Press release
Union members overwhelmingly approve strike action with 95.52% voting in favor on a 95.38% turnout, clearing the final legal hurdle after mediation ceased.Union emphasizes this is a fight against structural corporate governance issues, citing unresolved allegations concerning unfair labor practices and ESG compliance risks.Management adhered to a group-level wage guideline rather than bargaining on the basis of Samsung Biologics' own performance, exposing a lack of independent bargaining authority. The Samsung Biologics Labor Union (President: Jaesung Park), representing approximately 75% of the company's total employees, announced today that its members have overwhelmingly voted in favor of a strike, with 95.52% voting in favor on a 95.38% turnout during a voting period from March 24 to March 29. Following the Incheon Regional Labor Relations Commission's decision to cease mediation, the union has now secured the legal mandate to strike. The union stressed that this strike is not mere
The Premier Jumping League (PJL) Launches with a Record-Breaking $300 Million Guaranteed Prize Pot, Defining a New Era for Showjumping30.3.2026 11:00:00 CEST | Press release
The PJL empowers riders to compete as full-time professional athletes while working towards a sustainable economic model for the sport. Backed by McCourt Global and shaped by a leadership team with decades of experience in equestrian competition, sport, and entertainment, the PJL sets a new, sustainable, and globally relevant standard for elite jumping. Sixteen teams will compete across fourteen iconic international venues throughout Europe, North America, and the Middle East when the inaugural season opens in March 2027. The Premier Jumping League (PJL) launches with a record-breaking $300 million guaranteed prize pot, defining a new era for showjumping. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330990938/en/ Photography credits: Daniel Benson for The Premier Jumping League/ Wieden+Kennedy London Backed by McCourt Global and its Executive Chairman, Frank McCourt, the PJL is a groundbreaking global competition that e
Dompé Announces First Patient Enrolled in New Study of Intranasal NGF in Cerebral Palsy30.3.2026 11:00:00 CEST | Press release
Cerebral Palsy (CP) refers to a group of permanent disorders in the development of movement and posture, which causes activity limitations, and is attributed to non-progressive disturbances that occurred in the developing fetal or infant brain.1 Nerve growth factor (NGF) is a naturally-occurring protein that supports damaged nerve cells and improves nervous system signaling, Dompé is investigating whether intranasal NGF has the potential to improve movement and neurodevelopment and address underlying brain damage in people with CP. Dompé’s intranasal NGF platform builds on the Nobel Prize-winning discovery of neurobiologist Professor Rita Levi-Montalcini and biochemist Dr. Stanley Cohen. Dompé, a leading biopharmaceutical company with operations in Italy and in the U.S., announced that the first patient has been enrolled at the Agostino Gemelli IRCCS University Hospital in Rome, Italy, in a Phase 2 investigational study of an intranasal form of Nerve Growth Factor (NGF) (Cenegermin-bkb
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom